Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Change in Accured Expenses (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Change in Accured Expenses for 6 consecutive years, with -$371000.0 as the latest value for Q4 2018.

  • Quarterly Change in Accured Expenses fell 52.67% to -$371000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $144000.0 through Dec 2018, up 117.18% year-over-year, with the annual reading at -$334000.0 for FY2025, 122.09% down from the prior year.
  • Change in Accured Expenses hit -$371000.0 in Q4 2018 for Armata Pharmaceuticals, down from $648000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.3 million in Q3 2014 to a low of -$1.6 million in Q4 2014.
  • Historically, Change in Accured Expenses has averaged -$73081.2 across 5 years, with a median of -$112543.0 in 2015.
  • Biggest YoY gain for Change in Accured Expenses was 652.17% in 2017; the steepest drop was 516.43% in 2017.
  • Year by year, Change in Accured Expenses stood at -$1.6 million in 2014, then surged by 93.12% to -$112543.0 in 2015, then skyrocketed by 489.18% to $438000.0 in 2016, then plummeted by 155.48% to -$243000.0 in 2017, then plummeted by 52.67% to -$371000.0 in 2018.
  • Business Quant data shows Change in Accured Expenses for ARMP at -$371000.0 in Q4 2018, $648000.0 in Q3 2018, and $222000.0 in Q2 2018.